These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 8412642)

  • 1. Toxic oil syndrome. A long-term follow-up of a cohort of 332 patients.
    Alonso-Ruiz A; Calabozo M; Perez-Ruiz F; Mancebo L
    Medicine (Baltimore); 1993 Sep; 72(5):285-95. PubMed ID: 8412642
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cytokine mRNA expression in lung tissue from toxic oil syndrome patients: a TH2 immunological mechanism.
    del Pozo V; de Andrés B; Gallardo S; Cárdaba B; de Arruda-Chaves E; Cortegano MI; Jurado A; Palomino P; Oliva H; Aguilera B; Posada M; Lahoz C
    Toxicology; 1997 Mar; 118(1):61-70. PubMed ID: 9074654
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Toxic oil syndrome: a current clinical and epidemiologic summary, including comparisons with the eosinophilia-myalgia syndrome.
    Kilbourne EM; Posada de la Paz M; Abaitua Borda I; Diez Ruiz-Navarro M; Philen RM; Falk H
    J Am Coll Cardiol; 1991 Sep; 18(3):711-7. PubMed ID: 1869734
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Toxic oil syndrome--an example of an exogenously-induced autoimmune disease].
    Bell S; Brand K; Meurer M
    Hautarzt; 1992 Jun; 43(6):339-43. PubMed ID: 1628965
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Eosinophilia-myalgia syndrome, toxic-oil syndrome, and diffuse fasciitis with eosinophilia.
    Kaufman LD; Krupp LB
    Curr Opin Rheumatol; 1995 Nov; 7(6):560-7. PubMed ID: 8579979
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mortality among people affected by toxic oil syndrome.
    Abaitua Borda I; Kilbourne EM; Posada de la Paz M; Diez Ruiz-Navarro M; Gabriel Sanchez R; Falk H
    Int J Epidemiol; 1993 Dec; 22(6):1077-84. PubMed ID: 8144289
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Eosinophilia-myalgia syndrome, toxic-oil syndrome, and diffuse fasciitis with eosinophilia.
    Silver RM
    Curr Opin Rheumatol; 1993 Nov; 5(6):802-8. PubMed ID: 8117543
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Toxic oil syndrome and eosinophilia-myalgia syndrome: May 8-10, 1991, World Health Organization meeting report.
    Philen RM; Posada M
    Semin Arthritis Rheum; 1993 Oct; 23(2):104-24. PubMed ID: 8266108
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The neurotoxicological aspects of the toxic oil syndrome (TOS) in Spain.
    Altenkirch H; Stoltenburg-Didinger G; Koeppel C
    Toxicology; 1988 Apr; 49(1):25-34. PubMed ID: 3287691
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Eosinophilia-myalgia syndrome, toxic-oil syndrome, and diffuse fasciitis with eosinophilia.
    Bolster MB; Silver RM
    Curr Opin Rheumatol; 1994 Nov; 6(6):642-9. PubMed ID: 7865387
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Toxic oil syndrome: a syndrome with features overlapping those of various forms of scleroderma.
    Alonso-Ruiz A; Zea-Mendoza AC; Salazar-Vallinas JM; Rocamora-Ripoll A; Beltrán-Gutiérrez J
    Semin Arthritis Rheum; 1986 Feb; 15(3):200-12. PubMed ID: 3961509
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunohistochemical analysis of lymphocytes in postmortem study of the heart from fatal cases of the eosinophilia myalgia syndrome and of the toxic oil syndrome.
    Hayashi T; James TN
    Am Heart J; 1994 May; 127(5):1298-308. PubMed ID: 8172059
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical, pathologic, and immunopathologic manifestations of the toxic oil syndrome. Analysis of fourteen cases.
    Phelps RG; Fleischmajer R
    J Am Acad Dermatol; 1988 Feb; 18(2 Pt 1):313-24. PubMed ID: 3279088
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical and pathologic manifestations of pulmonary vascular disease in the toxic oil syndrome.
    Gomez-Sanchez MA; Saenz de la Calzada C; Gomez-Pajuelo C; Martinez-Tello FJ; Mestre de Juan MJ; James TN
    J Am Coll Cardiol; 1991 Nov; 18(6):1539-45. PubMed ID: 1939959
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Toxic oil syndrome: the perspective after 20 years.
    Posada de la Paz M; Philen RM; Borda AI
    Epidemiol Rev; 2001; 23(2):231-47. PubMed ID: 12192735
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Toxic oil syndrome: survival in the whole cohort between 1981 and 1995.
    Sánchez-Porro Valadés P; Posada de la Paz M; de Andrés Copa P; Gimenez Ribota O; Abaitua Borda I
    J Clin Epidemiol; 2003 Jul; 56(7):701-8. PubMed ID: 12921940
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biotransformation of 3-(phenylamino)-1,2-propanediol to 3-(phenylamino)alanine: a chemical link between toxic oil syndrome and eosinophilia-myalgia syndrome.
    Mayeno AN; Benson LM; Naylor S; Colberg-Beers M; Puchalski JT; Gleich GJ
    Chem Res Toxicol; 1995; 8(7):911-6. PubMed ID: 8555405
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pulmonary hypertension in patients with eosinophilia-myalgia syndrome or toxic oil syndrome.
    Cheng TO
    Mayo Clin Proc; 1993 Aug; 68(8):823-4. PubMed ID: 8331987
    [No Abstract]   [Full Text] [Related]  

  • 19. The toxic oil syndrome (TOS, 1981): from the disease towards a toxicological understanding of its chemical aetiology and mechanism.
    Aldridge WN
    Toxicol Lett; 1992 Dec; 64-65 Spec No():59-70. PubMed ID: 1471212
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Alterations in tryptophan metabolism in the toxic oil syndrome and in the eosinophilia-myalgia syndrome.
    Silver RM; Sutherland SE; Carreira P; Heyes MP
    J Rheumatol; 1992 Jan; 19(1):69-73. PubMed ID: 1532618
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.